Morgan Stanley Reviva Pharmaceuticals Holdings, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 6,120 shares of RVPH stock, worth $6,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,120
Previous 6,120
-0.0%
Holding current value
$6,854
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RVPH
# of Institutions
51Shares Held
7.83MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$2.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$1.55 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.36MShares$1.53 Million0.03% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$1.19 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT514KShares$575,9850.13% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $22.9M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...